These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 31419210)
1. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of Betts JW; Hornsey M; Higgins PG; Lucassen K; Wille J; Salguero FJ; Seifert H; La Ragione RM J Med Microbiol; 2019 Oct; 68(10):1552-1559. PubMed ID: 31419210 [No Abstract] [Full Text] [Related]
2. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG). Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815 [TBL] [Abstract][Full Text] [Related]
3. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa. Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466 [TBL] [Abstract][Full Text] [Related]
4. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
5. Steroidal alkaloids and conessine from the medicinal plant Holarrhena antidysenterica restore antibiotic efficacy in a Galleria mellonella model of multidrug-resistant Pseudomonas aeruginosa infection. Siriyong T; Voravuthikunchai SP; Coote PJ BMC Complement Altern Med; 2018 Oct; 18(1):285. PubMed ID: 30340578 [TBL] [Abstract][Full Text] [Related]
6. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model. Adamson DH; Krikstopaityte V; Coote PJ J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513 [TBL] [Abstract][Full Text] [Related]
7. A Galleria mellonella infection model reveals double and triple antibiotic combination therapies with enhanced efficacy versus a multidrug-resistant strain of Pseudomonas aeruginosa. Krezdorn J; Adams S; Coote PJ J Med Microbiol; 2014 Jul; 63(Pt 7):945-955. PubMed ID: 24928215 [TBL] [Abstract][Full Text] [Related]
9. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ mBio; 2017 Oct; 8(5):. PubMed ID: 29089424 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa. Yamagishi Y; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Nakai H; Mikamo H Chemotherapy; 2017; 62(2):105-110. PubMed ID: 27788502 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii. Betts JW; Wareham DW BMC Microbiol; 2014 Jun; 14():172. PubMed ID: 24969489 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp. Sader HS; Jones RN Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291 [TBL] [Abstract][Full Text] [Related]
13. In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli. Critchley IA; Sahm DF; Kelly LJ; Karlowsky JA Chemotherapy; 2003 May; 49(1-2):44-8. PubMed ID: 12714810 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella. Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845 [TBL] [Abstract][Full Text] [Related]
15. Chen H; Li H; Liu Z; Li J Microb Drug Resist; 2020 Sep; 26(9):1108-1119. PubMed ID: 32349617 [TBL] [Abstract][Full Text] [Related]
16. Esculentin-1a Derived Antipseudomonal Peptides: Limited Induction of Resistance and Synergy with Aztreonam. Casciaro B; Loffredo MR; Luca V; Verrusio W; Cacciafesta M; Mangoni ML Protein Pept Lett; 2018; 25(12):1155-1162. PubMed ID: 30381056 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin Wang L; Zhang Y; Lin Y; Cao J; Xu C; Chen L; Wang Y; Sun Y; Zheng X; Liu Y; Zhou T Microbiol Spectr; 2023 Feb; 11(1):e0199222. PubMed ID: 36475724 [TBL] [Abstract][Full Text] [Related]
18. Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG). Osterburg A; Gardner J; Hyon SH; Neely A; Babcock G Clin Microbiol Infect; 2009 Apr; 15(4):341-6. PubMed ID: 19431221 [TBL] [Abstract][Full Text] [Related]
19. In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan. Araoka H; Baba M; Tateda K; Ishii Y; Oguri T; Okuzumi K; Oishi T; Mori S; Mitsuda T; Moriya K; Nakamori Y; Ohmagari N; Yamaguchi K; Yoneyama A; Jpn J Infect Dis; 2012; 65(1):84-7. PubMed ID: 22274165 [TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii. Lee S; Razqan GS; Kwon DH Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]